Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.15 USD | -1.57% | +8.12% | +16.75% |
05-07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
05-07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Bio Therapeutic Drugs | -1.57% | +8.12% | +16.75% | +25.11% | +166.03% | 5.58B |
- Stock Market
- Equities
- HALO Stock
- Charts Halozyme Therapeutics, Inc.
- Relative Strength Chart